Vitality Watch

Dossier pubmed observational 04-jun-2026
Human cohort, case-control, or epidemiological association

Contribution of Obesity to Polypharmacy in U.S. Older Adults.

Key claim: Obesity significantly contributes to the prevalence and burden of polypharmacy among older adults in the United States.

Abstract

No abstract available.

Why this matters

Obesity significantly contributes to the prevalence and burden of polypharmacy among older adults in the United States.

Source

Link

Briefing card

Contribution of Obesity to Polypharmacy in U.S. Older Adults.
Stage: observational · pubmed · 04-jun-2026

Obesity significantly contributes to the prevalence and burden of polypharmacy among older adults in the United States.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1007/s11606-026-10458-8

build build 880 · 2bcef25 · 2026-11-18